Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service

American Journal of Surgical Pathology

Volumn 37, Issue 8, 2013, Pages 1150-1163

  Green, Whitney M ^a   Yonescu, Raluca ^a   Morsberger, Laura ^a   Morris, Kerry ^a   Netto, George J ^a   Epstein, Jonathan I ^a   Illei, Peter B ^a   Allaf, Mohamad ^a   Ladanyi, Marc ^b   Griffin, Constance A ^a   Argani, Pedram ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

FISH; renal cell carcinoma; TFE3; Xp11 translocation

Indexed keywords

BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; TFE3 PROTEIN, HUMAN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMISTRY; CHILD; EVALUATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATIENT REFERRAL; PHENOTYPE; PREDICTIVE VALUE; PROGNOSIS; X CHROMOSOME;

ADOLESCENT; ADULT; AGED; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOMA, RENAL CELL; CHILD; CHROMOSOMES, HUMAN, X; FEMALE; GENE REARRANGEMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PATHOLOGY, CLINICAL; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERRAL AND CONSULTATION; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84880571368     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31828a69ae     Document Type: Article

References (29)

1. Argani P, Ladanyi M. Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions. In: Eble JN, Sauter G, Epstein J, eds. Pathology and Genetics of Tumors of the Urinary System &Male Genital Organs. Lyon, France: IARC; 2004:37-38
2. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159:179-192
3. Argani P, Antonescu CR, Couturier J, et al. PRCC-TFE3 renal carcinomas: Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol. 2002;26:1553-1566
4. Clark J, Lu YJ, Sidhar SK, et al. Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene. 1997;15:2233-2239
5. Argani P, Lui MY, Couturier J, et al. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene. 2003;22:5374-5378
6. Argani P, Olgac S, Tickoo SK, et al. Xp11 translocation renal cell carcinoma in adults: Expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol. 2007;31:1149-1160
7. Martignoni G, PeaM, Gobbo S, et al. Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol. 2009;22:1016-1022
8. Martignoni G, Gobbo S, Camparo P, et al. Differential expression of cathepsin-K in neoplasms harbouring TFE3 gene fusions. Mod Pathol. 2011;24:1313-1319
9. Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: A sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003;27:750-761
10. Argani P, Hicks J, DeMarzo A, et al. Xp11 translocation renal cell carcinoma (RCC): Extended immunohistochemical (IHC) profile emphasizing novel RCC markers. Am J Surg Pathol. 2010;34:1295-1303
11. Argani P, Illei P, Netto G, et al. A distinctive subset of PEComas harbor TFE3 gene fusions. Am J Surg Pathol. 2010;34:1395-1406
12. Komai Y, Fujiwara M, Fujii Y, et al. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin Cancer Res. 2009;15:1170-1176
13. Zhong M, De Angelo P, Osborne L, et al. Translocation renal cell carcinomas in adults: A single-institution experience. Am J Surg Pathol. 2012;36:654-662
14. Sukov WR, Hodge JC, Lohse CM, et al. TFE3 rearrangements in adult renal cell carcinoma: Clinical and pathologic features with outcome in a large series of consecutively treated patients. Am J Surg Pathol. 2012;36:663-670
15. Mosquera JM, Dal Cin P, Mertz KD, et al. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma. Diagn Mol Pathol. 2011;20:129-137
16. Ladanyi M, Lui MY, Antonescu CR, et al. The der(17)t(X;17) (p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene. 2001;20:48-57
17. Wiktor AE, Van Dyke DL, Stupca PJ, et al. Preclinical validation of fluorescence in situ hybridization assays for clinical practice. Genet Med. 2006;8:16-23
18. Argani P, Laé M, Ballard ET, et al. Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol. 2006; 24:1529-1534
19. Armah HB, Parwani AV, Surti U, et al. Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: A case report with review of the literature. Diagn Pathol. 2009;4:15
20. Bovio IM, Allan RW, Oliai BR, et al. Xp11 translocation renal carcinoma with placental metastasis: A case report. Int J Surg Pathol. 2011;19:80-83
21. Aydin H, Chen L, Cheng L, et al. Clear cell tubulopapillary renal cell carcinoma: A study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol. 2010;34:1608-1621
22. Al-Ahmadie HA, Alden D, Qin LX, et al. Carbonic anhydrase IX expression in clear cell renal cell carcinoma: An immunohistochemical study comparing 2 antibodies. Am J Surg Pathol. 2008; 32:377-382
23. Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in end-stage renal disease: An experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol. 2006;30:141-153
24. Ross H, Martignoni G, Argani P. Renal cell carcinomas with clear cell and papillary features. Arch Pathol Lab Med. 2012;136: 391-399
25. Pea M, Bonetti F, Martignoni G, et al. Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous: The identification of malignant epithelioid angiomyolipoma. Am J Surg Pathol. 1998;22:180-187
26. Macher-Geoppinger S, Roth W, Wagener N, et al. Molecular heterogeneity of TFE3 activation in renal cell carcinomas. Mod Pathol. 2012;25:308-315
27. Suzigan S, Drut R, Faria P, et al. Xp11 translocation carcinoma of the kidney presenting with multilocular cystic renal cell carcinomalike features. Int J Surg Pathol. 2007;15:199-203
28. Argani P, Laé M, Hutchinson B, et al. Renal carcinomas with the t(6;11)(p21;q12). Clinicopathologic features and demonstration of the specific Alpha-TFEB gene fusion by immunohistochemistry, RTPCR, and DNA-PCR. Am J Surg Pathol. 2005;29:230-240
29. Argani P, Yonescu R, Morsberger L, et al. Molecular confirmation of the t(6;11)(p21;q12) renal cell carcinoma in archival paraffinembedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum. Am J Surg Pathol. 2012;36:1516-1526